CORRELATION BETWEEN NEPHROTOXICITY AND PHARMACOKINETIC PARAMETERS OF GENTAMICIN

被引:7
作者
ELSAYED, YM
机构
[1] Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451
关键词
D O I
10.1111/j.1365-2710.1994.tb00686.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Gentamicin pharmacokinetics were determined in 26 critically ill adult patients. All had normal or only moderately reduced renal function based on serum creatinine concentration and clearance. The average half-life of elimination was 4.68 h, creatinine clearance was 3.9 1/h, and gentamicin clearance was 2.86 l/h. There was a highly significant correlation between the area under the serum concentration-time curves (AUC) and the peak and trough concentrations (r=0.908, 0.980, P<0.05, respectively). Serum gentamicin concentrations rose rapidly in 10 patients who showed deterioration of kidney function after 5 days of therapy. Gentamicin peak concentrations increased by 31%, while trough concentration increased by 121%. The mean percentage change in half-life was 68.49%, while the mean percentage change in renal function was 44.38%. Linear regression analysis of AUC versus the percentage change in kidney function revealed a significant increase in AUC with decrease in kidney function (r=0.909, P<0.05). There was a significant increase in half-life with decrease in kidney function (r=0.948, P<0.05).
引用
收藏
页码:267 / 271
页数:5
相关论文
共 23 条
[1]   PREDICTABILITY OF BLOOD-LEVELS OF GENTAMICIN IN MAN [J].
BARZA, M ;
BROWN, RB ;
SHEN, D ;
GIBALDI, M ;
WEINSTEIN, L .
JOURNAL OF INFECTIOUS DISEASES, 1975, 132 (02) :165-174
[2]   WHY MONITOR SERUM LEVELS OF GENTAMICIN [J].
BARZA, M ;
LAUERMANN, M .
CLINICAL PHARMACOKINETICS, 1978, 3 (03) :202-215
[3]  
BOWLES SK, 1986, APPLIED PHARMACOKINE, P382
[4]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[5]   GENTAMICIN BLOOD-LEVELS - GUIDE TO NEPHROTOXICITY [J].
DAHLGREN, JG ;
ANDERSON, ET ;
HEWITT, WL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1975, 8 (01) :58-62
[7]   COMPARISON OF NONKINETIC AND KINETIC APPROACHES TO INDIVIDUALIZATION OF GENTAMICIN DOSAGE [J].
ELSAYED, YM ;
ISLAM, SI .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 39 (02) :155-159
[8]  
ELSAYED YM, 1989, INT J CLIN PHARM TH, V27, P503
[9]  
FEDERSPIL P, 1976, J INFECT DIS S, V134, P200
[10]   PLASMA-CONCENTRATION MONITORING OF AMINOGLYCOSIDES [J].
FOLLATH, F ;
WENK, M ;
VOZEH, S .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1981, 8 :37-43